ARS Pharmaceuticals, Inc. SPRY Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: ARS Pharmaceuticals, Inc.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s income tax?
- ARS Pharmaceuticals, Inc. (SPRY) reported income tax of -$20K in Q4 2025.
- How has ARS Pharmaceuticals, Inc.'s income tax changed year-over-year?
- ARS Pharmaceuticals, Inc.'s income tax decreased by 127.8% year-over-year, from $72K to -$20K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.